Atlas Trials

Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine

Clinical trial NCT04161066 · RECRUITING

Trial details

NCT number
NCT04161066
Sponsor
University of Wisconsin, Madison
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Opioid Use Disorder
Start date
2021-01-13
Primary completion
2026-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.